Free Trial

Talaris Therapeutics (TALS) News Today

→ We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (From Paradigm Press) (Ad)
Free TALS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Stock AnalysisCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipTrends
April 29, 2024 | finanznachrichten.de
Cullinan Therapeutics, Inc.: Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer
February 25, 2024 | benzinga.com
Longitude Venture Partners III, L.P.'s Net Worth
December 12, 2023 | marketbeat.com
RA Capital Management L.P. Takes Position in Talaris Therapeutics, Inc. (NASDAQ:TALS)
RA Capital Management L.P. acquired a new stake in shares of Talaris Therapeutics, Inc. (NASDAQ:TALS - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 2,333,175 shares of the company's stock, valu
November 1, 2023 | msn.com
Talaris Therapeutics (TALS) Price Target Increased by 562.50% to 135.15
October 19, 2023 | msn.com
Talaris Therapeutics goes ex-dividend tomorrow
October 18, 2023 | finanznachrichten.de
Talaris Therapeutics, Inc.: Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
October 17, 2023 | msn.com
Talaris shareholders approve merger, 1-for-10 reverse stock split
October 17, 2023 | finance.yahoo.com
Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
October 6, 2023 | marketwatch.com
Shares of Talaris Therapeutics Climb 5.2% on Special Dividend Tied to Merger
October 6, 2023 | finance.yahoo.com
Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio
October 4, 2023 | finance.yahoo.com
New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris Therapeutics
September 12, 2023 | finance.yahoo.com
We're Keeping An Eye On Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate
September 7, 2023 | marketbeat.com
Acadian Asset Management LLC Raises Holdings in Talaris Therapeutics, Inc. (NASDAQ:TALS)
Acadian Asset Management LLC lifted its stake in Talaris Therapeutics, Inc. (NASDAQ:TALS - Free Report) by 114.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 238,513 shares of the company's stock after purchasing an additiona
August 15, 2023 | markets.businessinsider.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, DEN, TALS, QUOT
August 14, 2023 | finance.yahoo.com
ImmunoFree Inc. has Acquired Talaris Therapeutics, Inc.'s Tolerance Business
August 8, 2023 | markets.businessinsider.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEX, TALS, QUOT, SURF
July 28, 2023 | benzinga.com
Moore Kuehn Encourages RETA, TALS, INPX, and DEN Investors to Contact Law Firm
July 27, 2023 | markets.businessinsider.com
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Talaris Therapeutics, Inc. (TALS)
July 18, 2023 | markets.businessinsider.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, QUOT, TALS, CFMS
July 18, 2023 | msn.com
Talaris Therapeutics: Cashing Out Ahead Of Tourmaline Merger
July 14, 2023 | marketbeat.com
Short Interest in Talaris Therapeutics, Inc. (NASDAQ:TALS) Decreases By 71.7%
Talaris Therapeutics, Inc. (NASDAQ:TALS - Get Free Report) was the target of a significant decrease in short interest in June. As of June 30th, there was short interest totalling 270,300 shares, a decrease of 71.7% from the June 15th total of 955,200 shares. Based on an average daily trading volume, of 629,200 shares, the days-to-cover ratio is currently 0.4 days. Currently, 1.3% of the shares of the stock are sold short.
July 6, 2023 | msn.com
Talaris Therapeutics (TALS) Price Target Increased by 66.67% to 12.75
June 27, 2023 | markets.businessinsider.com
IMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, DICE, NEX, NETI
June 26, 2023 | businesswire.com
TALARIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Talaris Therapeutics, Inc. - TALS
June 23, 2023 | benzinga.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Talaris Therapeutics, Inc. Merger
June 23, 2023 | bizjournals.com
Talaris Therapeutics announces merger after layoffs
June 22, 2023 | bizjournals.com
NY biotech to go public by merging with Boston firm that laid off 95% of staff
June 22, 2023 | msn.com
Talaris jumps 29% on merger with Tourmaline Bio in all-stock deal
June 22, 2023 | markets.businessinsider.com
IMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, SURF, NEX, CIR
June 22, 2023 | finanznachrichten.de
Talaris Therapeutics, Inc.: Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
June 22, 2023 | msn.com
Talaris Soars on All Stock Deal with Tourmaline Bio
June 22, 2023 | stockhouse.com
TALS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Talaris Therapeutics, Inc. Is Fair to Shareholders
June 22, 2023 | benzinga.com
Why Talaris Therapeutics Stock Is Shooting Higher Today
June 22, 2023 | seekingalpha.com
Talaris to merge with Tourmaline Bio in all-stock deal
June 22, 2023 | markets.businessinsider.com
Tourmaline, Talaris Announce All-stock Merger
June 22, 2023 | finance.yahoo.com
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
June 22, 2023 | marketbeat.com
Trading was temporarily halted for "TALS" at 07:06 AM with a stated reason of "News pending."
June 15, 2023 | benzinga.com
Talaris Therapeutics Board Member Awarded $50K Worth of Stock Options
June 15, 2023 | benzinga.com
Talaris Therapeutics Director Awarded $50K Worth of Stock Options
June 9, 2023 | marketbeat.com
Talaris Therapeutics, Inc. (NASDAQ:TALS) Director Sells $62,530.74 in Stock
Talaris Therapeutics, Inc. (NASDAQ:TALS - Get Rating) Director Suzanne Ildstad sold 25,419 shares of the stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $2.46, for a total value of $62,530.74. Following the sale, the director now owns 3,815,412 shares of the company's stock, valued at approximately $9,385,913.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
May 26, 2023 | finanznachrichten.de
Talaris Therapeutics, Inc.: Talaris Therapeutics Announces Leadership Transition
May 26, 2023 | markets.businessinsider.com
Talaris Therapeutics Names Mary Kay Fenton Interim CEO & President - Quick Facts
May 26, 2023 | msn.com
Talaris Therapeutics appoints current CFO Mary Kay as interim CEO
May 26, 2023 | finance.yahoo.com
Talaris Therapeutics Announces Leadership Transition
May 20, 2023 | finance.yahoo.com
Talaris Therapeutics, Inc. (NASDAQ:TALS) most popular amongst private equity firms who own 34% of the shares, institutions hold 30%
May 19, 2023 | marketbeat.com
Q2 2023 EPS Estimates for Talaris Therapeutics, Inc. (NASDAQ:TALS) Increased by SVB Leerink
Talaris Therapeutics, Inc. (NASDAQ:TALS - Get Rating) - Investment analysts at SVB Leerink lifted their Q2 2023 earnings per share (EPS) estimates for Talaris Therapeutics in a research report issued on Tuesday, May 16th. SVB Leerink analyst M. Foroohar now anticipates that the company will post
May 3, 2023 | bizjournals.com
Wellesley biotech announces 2nd round of layoffs this year, closure of Kentucky facilities
May 2, 2023 | bizjournals.com
Talaris Therapeutics closing Louisville facilities, laying off 51
April 18, 2023 | benzinga.com
Talaris Therapeutics Stock (NASDAQ:TALS), Dividends
April 5, 2023 | markets.businessinsider.com
SVB Securities Reaffirms Their Hold Rating on Talaris Therapeutics (TALS)
Get Talaris Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TALS and its competitors with MarketBeat's FREE daily newsletter.

Breaking - The US Gov. Seized CITGO (Ad)

Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).

Get all the details here.

TALS Media Mentions By Week

TALS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TALS
News Sentiment
▼
0.00

0.73
▲
Average
Medical
News Sentiment

TALS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TALS Articles
This Week
▼
0

0
▲
TALS Articles
Average Week

Get Talaris Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TALS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:TALS) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners
Millionaire-Making “Wealth Pattern” Just Repeated on April 22
If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.
Paradigm Press | Sponsored
Breaking - The US Gov. Seized CITGO
Do you want an investment that can double or triple your money in the next three months? The US Court is cu...
Augury Research | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
AI Hell Will Break Loose [June 30, 2024] …
On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...
Banyan Hill Publishing | Sponsored
Was the Great Financial Crisis fun?
The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...
Brooks Enterprises | Sponsored
Collapse of the Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...
Colonial Metals | Sponsored